Stay informed with our live blog covering India’s latest in politics, economy, crime, and general news. Get real-time updates ...

Then, feature your greatest accomplishments and highest impact in résumé bullets. These types of change need efforts at all levels of the organization. Whether you led, were on the team ...

(RTTNews) - Matthews International Corp. (MATW), Thursday announced a favorable arbitration ruling in its dispute with Tesla, confirming its right to sell Dry Battery Electrode or DBE technology ...

Jason Mercer, Chief Market Analyst at the Toronto Regional Real Estate Board, on a 12.4 per cent increase in home sales for 2025.

Qualcomm on Wednesday forecast sales and profits above analyst expectations as artificial intelligence features helped drive sales of the smartphones, laptops and other devices powered by its chips.

27% higher than previously forecast, helped by strong sales and the weakening yen. The profit forecast remains 8.6% lower than last year's profit figure, dragged lower by certification ...

(Reuters) - Qualcomm on Wednesday forecast sales and profits above analyst expectations as artificial intelligence features helped fuel demand for smartphones, and its share price fell after the ...

Melexis, Belgium's largest semiconductor supplier, on Wednesday forecast lower margin and sales for the first half of 2025, sending its shares to nearly five-year lows, as inventory corrections by ...

For its current fiscal second quarter, Qualcomm forecast a sales range with a midpoint of $10.75 billion and adjusted profits of $2.80 per share, both above analyst estimates of sales of $10.34 ...

(AP Photo/Matt Rourke, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 ...

Merck gave no explanation in its fourth-quarter earnings report for the pause, but sales of Gardasil fell 17% to $1.55 billion (approx. €1.47bn) in the final quarter of last year, mainly due to ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.